Levy E J, Anderson M E, Meister A
Department of Biochemistry, Cornell University Medical College, New York, NY 10021.
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9171-5. doi: 10.1073/pnas.90.19.9171.
Glutathione monoesters in which the carboxyl group of the glycine residue is esterified were previously found, in contrast to glutathione itself, to be effectively transported into various types of cells and to be converted intracellularly into glutathione. Glutathione monoesters are thus useful for prevention of oxidative stress, certain toxicities, and for treatment of glutathione deficiency. Glutathione diethyl ester is rapidly split to the glutathione monoethyl ester by mouse plasma glutathione diester alpha-esterase activity. Thus, as expected, glutathione mono- and diesters have similar effects on cellular glutathione levels in mice. However, human plasma lacks glutathione diester alpha-esterase; thus, it became of interest to compare the transport properties of glutathione mono- and diesters in human cells. We found that human cells (erythrocytes, peripheral blood mononuclear cells, fibroblasts, ovarian tumor cells, and purified T cells) transport glutathione diethyl ester much more effectively than the corresponding monoethyl (glycyl) ester. Human cells rapidly convert glutathione diethyl ester to the monoester, whose intracellular levels rise to levels that are significantly higher than levels found after application of the monoester to the cells. High levels of the monoester provide the cells with a means of producing glutathione over a period of time. We conclude that glutathione diethyl ester is highly effective as a delivery agent for glutathione monoester, and thus for glutathione, in human cells and therefore could serve to decrease oxidative stress and toxicity. Hamster (and certain other animals) also lack plasma glutathione diester alpha-esterase and therefore would be suitable animal models. Previously reported toxicity of certain glutathione ester preparations appears to reflect the presence of impurities rather than effects of the esters.
与谷胱甘肽本身不同,先前发现甘氨酸残基的羧基被酯化的谷胱甘肽单酯能有效地转运到各种类型的细胞中,并在细胞内转化为谷胱甘肽。因此,谷胱甘肽单酯可用于预防氧化应激、某些毒性以及治疗谷胱甘肽缺乏症。谷胱甘肽二乙酯可通过小鼠血浆谷胱甘肽二酯α -酯酶活性迅速裂解为谷胱甘肽单乙酯。因此,正如预期的那样,谷胱甘肽单酯和二酯对小鼠细胞内谷胱甘肽水平有相似的影响。然而,人血浆缺乏谷胱甘肽二酯α -酯酶;因此,比较谷胱甘肽单酯和二酯在人细胞中的转运特性就变得很有意义。我们发现人细胞(红细胞、外周血单核细胞、成纤维细胞、卵巢肿瘤细胞和纯化的T细胞)转运谷胱甘肽二乙酯的效率比相应的单乙酯(甘氨酰)酯高得多。人细胞能迅速将谷胱甘肽二乙酯转化为单酯,其细胞内水平上升到显著高于将单酯应用于细胞后所发现的水平。高水平的单酯为细胞提供了一种在一段时间内产生谷胱甘肽的方式。我们得出结论,谷胱甘肽二乙酯作为谷胱甘肽单酯进而作为谷胱甘肽的递送剂在人细胞中非常有效,因此可用于降低氧化应激和毒性。仓鼠(以及某些其他动物)也缺乏血浆谷胱甘肽二酯α -酯酶,因此将是合适的动物模型。先前报道的某些谷胱甘肽酯制剂的毒性似乎反映了杂质的存在而非酯的作用。